CaHA Injectable for Facial Use Gains Regulatory Approval in China
The approval makes it the first calcium hydroxylapatite microsphere injectable product approved in China for facial soft tissue augmentation, according to the company.
The approval makes it the first calcium hydroxylapatite microsphere injectable product approved in China for facial soft tissue augmentation, according to the company.
The Women and Equalities Committee's report highlights patient safety failures tied to unregulated surgical and non-surgical cosmetic procedures, including gaps in data collection, informed consent, and clinical oversight.